IQVIA

Articles

Investigator Payments – A Critical Component in Bayer’s Sponsor of Choice Strategy

July 20, 2021

Tuesday, July 20, 2021 at 11am EDT It’s not often that a sponsor calls a clinical trial solution “life-changing,” but that’s how Bayer is describing the impact of IQVIA Clinical Trial Payments as the solution rolls out to more than 20 countries. Learn how it’s possible to pay sites 2-3 times faster, eliminate end-of-study reconciliation, and reduce time spent supporting payment processes by up to 90%.

Patient Centricity by Design – Improving patient engagement and retention while reducing burden with fit-for-purpose technology

July 14, 2021

Wednesday, July 14, 2021 at 11am EDT Looking for tested strategies to design and deliver truly patient-centric clinical trials? Join IQVIA experts for an insightful webinar on “Patient Centricity by Design: Improving patient engagement and retention while reducing burden with fit-for-purpose technology,” where you’ll hear how to enhance recruitment, strengthen patient and site relationships and deliver faster access through intelligent connections and decentralized trials approaches.

Connected Data Flow and Standards: A data management approach combining standards, technology and data flow to accelerate FSP clinical development

June 11, 2021

*** Friday, June 11, 2021 at 11am EDT *** Data plays a central role within drug discovery and as decentralized trials become more prevalent in the industry, the need to process and engage with enterprise level solutions and the integration of technology to map data to standards become a must. As the central conduit to this IQVIA data management will share the importance of how systemic compliance to standards together with a central data strategy can accelerate clinical development across an organization through an innovative FSP approach.***On demand available after final airing until June 11, 2022***

How Cloud Technologies are Enabling the Decentralization of Clinical Trials

May 19, 2021

*** Wednesday, May 19, 2021 at 12pm EDT *** Join partners IQVIA Technologies and Salesforce for this webinar where we explore a new paradigm in life sciences where virtualization of clinical trials, both for patients and sites, has become a reality, and why it has become the industry’s new technological imperative. ***On demand available after final airing until May 19, 2022***

Through Obstacles and Beyond: The Value of Building Strategic Site Relationships

May 04, 2021

*** Wednesday, May 4, 2021 at 11am EDT *** Driving faster site activation for any clinical trial requires close interactions with sponsors to seamlessly execute a breadth of requirements to stay compliant while delivering to new levels of efficiencies ***On demand available after final airing until May 4, 2022***

Trials and Tribulations of Electronic Patient Consent: Removing Barriers to eConsent Adoption

April 28, 2021

*** Wednesday, April 28, 2021 at 11am EDT *** After a decade of dabbling with eConsent, it’s time for sponsors and technology providers to meet the demand to bring clinical trials directly to the patient at a global scale. Join this webinar to learn how to overcome the persistent challenges in eConsent adoption and deliver the promise of decentralized trials. ***On demand available after final airing until Apr. 28, 2022***

RBM Case Studies: AI-ML Implementation and Shifts in Clinical Operating Models – Defining monitoring of the future

April 05, 2021

*** Monday, April 5, 2021 at 11am EDT *** Risk-based monitoring (RBM) continues to evolve and adapt to industry needs. Understand how innovative technologies and methodologies are driving new levels of study quality and changing clinical monitoring and how artificial intelligence, machine learning, predictive and advanced analytics are improving patient safety and overall study quality and operational efficiencies. ***On demand available after final airing until Apr. 5, 2022***

Clinical Development of Oncology Products in Japan – the 2nd Largest Market for Innovation

November 19, 2020

*** Thursday, November 19, 2020 | 4:00 pm-5:00 pm EST ***Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. In addition, the Japanese market is driven by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness, and identifiable patient populations, amongst other factors. ***On demand available after final airing until Nov. 19, 2021***

Implementing Risk-based Monitoring in Oncology Trials Sharing case studies and insights on the impact to study quality and patient safety

October 29, 2020

***Live: Thursday November 12, 2020 at 11am EST***Oncology trials of various types and phases present unique challenges for effectively conducting trials, and firms are implementing risk-based monitoring (RBM) practices to improve quality and patient safety.***On demand available after final airing until Nov. 12, 2021***

Use of RWE in Clinical Development to Enhance Regulatory Submission

April 07, 2020

Learn more about global regulatory acceptance of real-world evidence in a regulatory submission. Understand how to identify opportunities to incorporate real-world Evidence in your submission package. Live: Tuesday, Apr. 7, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Apr. 7, 2021. Register free